Inmune Bio, Inc. (INMB) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 84 transactions totaling $7.7M, demonstrating a bearish sentiment with -$2.8M in net insider flow. The most recent transaction on Sep 30, 2024 involved a purchase of 10,000 shares valued at $52.9K.
No significant insider buying has been recorded for INMB in the recent period.
No significant insider selling has been recorded for INMB in the recent period.
Based on recent SEC filings, insider sentiment for INMB is bearish with an Insider Alignment Score of 32/100 and a net flow of -$2.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Inmune Bio, Inc. (INMB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading INMB stock, having executed 84 transactions in the past 90 days. The most active insider is Inc Xencor (Executive), who has made 4 transactions totaling $10.7M.
Get notified when executives and directors at INMB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | J. Moss David | Executive | Purchase | 10,000 | $5.29 | $52.9K | |
| Sep 12, 2024 | J. Moss David | Executive | Purchase | 7,690 | $6.38 | $49.1K | |
| Sep 12, 2024 | Joseph Tesi Raymond | Executive | Purchase | 15,380 | $6.38 | $98.1K | |
| Jun 25, 2024 | Juda Scott | Executive | Purchase | 5,000 | $7.27 | $36.4K | |
| Apr 19, 2024 | Juda Scott | Executive | Award | 29,603 | $8.32 | $246.3K | |
| Apr 19, 2024 | William Lowdell Mark | Executive | Award | 14,423 | $8.32 | $120.0K | |
| Apr 19, 2024 | J. Moss David | Executive | Award | 18,028 | $8.32 | $150.0K | |
| Apr 19, 2024 | Joseph Tesi Raymond | Executive | Award | 18,028 | $8.32 | $150.0K | |
| Apr 19, 2024 | Juda Scott | Executive | Purchase | 29,603 | $8.32 | $246.3K | |
| Apr 19, 2024 | William Lowdell Mark | Executive | Purchase | 14,423 | $8.32 | $120.0K | |
| Apr 19, 2024 | Joseph Tesi Raymond | Executive | Purchase | 18,028 | $8.32 | $150.0K | |
| Apr 19, 2024 | J. Moss David | Executive | Purchase | 18,028 | $8.32 | $150.0K | |
| Nov 10, 2023 | Juda Scott | Executive | Purchase | 7,000 | $6.95 | $48.6K | |
| Jul 12, 2023 | J. Schroeder Timothy | Executive | Sale | 10,000 | $11.01 | $110.1K | 10b5-1 |
| Mar 17, 2023 | J. Moss David | Executive | Purchase | 2,500 | $6.43 | $16.1K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Other(J) | 3 | $9.9M | 49.5% |
Sale(S) | 23 | $5.2M | 26.2% |
Purchase(P) | 47 | $2.4M | 12.1% |
Award(A) | 8 | $1.4M | 6.8% |
Exercise(M) | 3 | $1.1M | 5.3% |
Insider selling pressure at Inmune Bio, Inc. has increased, with 8 insiders executing 84 transactions across all time. Total sales of $5.2M significantly outpace purchases of $2.4M, resulting in a net outflow of $2.8M. This selling activity appears largely discretionary, which may warrant closer attention from investors.